Gynecology; Endothelin receptor blockade may eliminate COX-2- associated ovarian cancer: 1
Gynecology; Endothelin receptor blockade may eliminate COX-2- associated ovarian cancer: 1
About this item
Full title
Gynecology; Endothelin receptor blockade may eliminate COX-2- associated ovarian cancer: 1
Publisher
Atlanta: NewsRx
Journal title
Drug Week, 2005, p.384
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
"In human ovarian xenografts, the levels of cyclooxygenase-2 protein expression were significantly reduced following treatment with the endothelin-A receptor selective antagonist, atrasentan, compared with untreated mice. These results suggest that the pharmacological blocking of endothelin-A receptor is an attractive strategy to control the cycloo...
Alternative Titles
Full title
Gynecology; Endothelin receptor blockade may eliminate COX-2- associated ovarian cancer: 1
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_206359970
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_206359970
Other Identifiers
ISSN
1531-6440
E-ISSN
1532-4575
How to access this item
Log in as a Library member
